Get involved / Coming in 2027

Help shape what MATILDA becomes.

MATILDA is coming in 2027. This is an opportunity for people living with type 2 diabetes, care professionals and potential partners to help shape a more useful health experience before launch.

Three ways to participate

A different conversation for every perspective.

Choose the pathway that best describes your interest. Each starts with a conversation—not an automatic enrollment, partnership or investment process.

Individuals & caregivers

Bring lived experience into the product.

Help MATILDA understand the questions, routines and friction that matter in everyday life.

  • Product and language feedback
  • Usability conversations
  • Early-access interest

Explore this pathway ↓

Clinicians & care teams

Shape a more useful clinical view.

Discuss longitudinal context, provider workflows and better-prepared care conversations.

  • Workflow feedback
  • Design-partner discussions
  • Research and validation priorities

Explore this pathway ↓

Investors

Explore the company behind MATILDA.

Start a focused conversation about the product, technology, market and company direction.

  • Company introduction
  • Product and technology overview
  • Approved investor materials

Explore this pathway ↓

01 · INDIVIDUALS & CAREGIVERS

Start with the questions daily life creates.

People living with type 2 diabetes and the people supporting them bring essential context to how MATILDA communicates, organizes information and fits into a routine.

Join the individual interest route

Share friction pointsDescribe which parts of tracking, remembering and preparing for appointments feel unnecessarily difficult.
Review product languageHelp identify explanations that feel clear, respectful and useful instead of overly technical.
Discuss usabilityGive feedback on concepts and workflows when an appropriate feedback opportunity is available.
Express early-access interestLet the team know you would like to hear about confirmed access opportunities.
Do not submit glucose readings, diagnoses, medication details or medical histories through an interest form. Expressing interest does not establish a care relationship, guarantee access or enroll anyone in research.
02 · CLINICIANS & CARE TEAMS

Bring clinical workflow into the design conversation.

Clinicians, diabetes educators and care-team leaders can help define how patient-authorized history becomes useful before, during and between visits.

Discuss a clinical collaboration

Review provider workflowsDiscuss what information is useful, when it should appear and how it fits into existing care processes.
Shape longitudinal summariesExplore how readings, routines and personal context can support a clearer patient history.
Consider design-partner workDiscuss an appropriate feedback, pilot or product-design relationship when a defined opportunity exists.
Define evidence prioritiesIdentify responsible research questions, validation needs and measures that matter to care teams.
Never submit identifiable patient information through this page. MATILDA supports clinician review; it does not provide emergency monitoring, make final medical decisions or automatically dispatch assistance.
03 · INVESTORS

Explore a personalized health-data company built around context.

MATILDA combines a connected health experience with an in-house individualized machine-learning model designed to learn from each user over time.

Start an investor conversation

Company thesisUnderstand the problem MATILDA addresses and why fragmented health signals limit everyday usefulness.
Product differentiationReview how individualized modeling, traceable reasoning and patient-authorized care-team access work together.
Market focusDiscuss the initial type 2 diabetes focus, intended audiences and responsible path to market.
Approved materialsRequest an introductory conversation and the materials appropriate to the stage and relationship.
Confidential materials, projections and investment documentation are shared intentionally—not published openly. Nothing on this page is an offer to sell or a solicitation to buy securities.
How participation works

A clear first step without an automatic commitment.

The route begins with enough information to understand the request. The next step depends on fit, readiness and the opportunities available.

01Choose where you fitSelect the individual, clinician or investor pathway.
02Share your interestProvide basic contact and role information without sensitive health or patient data.
03Find the appropriate next stepThat may be a conversation, feedback opportunity, update or request for additional information.
Start the conversation

Tell MATILDA which perspective you bring.

Use the verified contact route and identify yourself as an individual or caregiver, clinician or care-team professional, or investor.

Keep the introduction focused.

A useful first message explains your role, which pathway interests you and the kind of conversation you would like to have.

Name and preferred contact informationIndividual, clinician or investor pathwayRole or organization when relevantA short description of your interestNo patient records or sensitive health information
Specific programs, access, partnerships and timelines are discussed only when confirmed. Expressing interest does not create a care relationship, guarantee product access, establish a partnership or create an investment relationship.
Another kind of collaboration?

Research, advocacy, media and mission-aligned conversations are welcome through the general route.

Scroll to Top